Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
9 drugs in development
By Therapeutic Area
top 5
R&D Momentum
87/100
Pipeline Velocity
57/100
Trial Completion Rate
68/100
Pipeline Concentration
25/100
Pipeline Freshness
55/100
Strategic Signals
Activity
Last 14 days
Genetic Basis of Melanocytic Nevi
Aesthetic Outcome of Tie-over Bolster Application in Surgical Wounds: a Randomized Evaluator-blinded Split-wound Comparative Effectiveness Trial.
Can Fidgeting Lead to Enhanced Attention and Emotional Regulation in ADHD?
CHAT-OA: Conversations in Health Literacy Using AI Technology for Osteoarthritis Patients
Imaging of Glial Activation and Risk for Post-Traumatic Epilepsy
Prospective Evaluation of California's Armed and Prohibited Persons System
Preventing Type 2 Diabetes Following Gestational Diabetes: Implementation Mapping for a Multilevel Breastfeeding Support Strategy
Flavanol Intake in Davis (FID) Study: Biomarker-estimated Habitual (-)-Epicatechin and Flavanol Intake in Adults
Pinch Grafting Versus Second Intention Wound Healing for Mohs Micrographic Surgery Defects on the Scalp
Randomized Controlled Clinical Trial to Gauge the Effects of Dietary Erythritol on Platelet Reactivity and Vascular Inflammation
Factors That Affect the Outcomes of Cardiothoracic and Vascular Surgery
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)